Artelo ART26.12 Osteoarthritis Study: Relief Like Naproxen
Artelo Biosciences (Nasdaq: ARTL) reported new nonclinical data showing its selective FABP5 inhibitor ART26.12 reduced…
Browsing Tag
nonclinical study
1 post